Last edition
News about "Integris Medtech Secures SEBI Nod for INR 925 Cror"
Integris Medtech Secures SEBI Nod for INR 925 Crore IPO
Integris Medtech, the second-largest Indian-headquartered diversified medical technology platform by operating revenue in FY25, has received approval from the Securities and Exchange Board of India (SEBI) to proceed with its proposed initial public offering (IPO).
Integris Medtech Secures SEBI Nod For INR 925 Cror | 25/02/2026 | By Darshana | 133
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members